home / stock / aim / aim news


AIM News and Press, AIM ImmunoTech Inc.

Stock Information

Company Name: AIM ImmunoTech Inc.
Stock Symbol: AIM
Market: NYSE
Website: aimimmuno.com

Menu

AIM AIM Quote AIM Short AIM News AIM Articles AIM Message Board
Get AIM Alerts

News, Short Squeeze, Breakout and More Instantly...

AIM - AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference

OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Pitch Con...

AIM - AIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series

OCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series ...

AIM - AIM ImmunoTech announces pricing of $2.0M registered direct offering

2024-05-31 08:59:45 ET More on AIM ImmunoTech AIM ImmunoTech Inc. (AIM) Q1 2024 Earnings Call Transcript AIM ImmunoTech Inc. (AIM) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on AIM ImmunoTech Historical earnings data for AIM ImmunoTe...

AIM - AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering

OCALA, Fla., May 31, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 5,640,958 shares of common stoc...

AIM - AI-Media set to Showcase Cutting-Edge Captioning Solutions at Broadcast Asia Expo 2024

SINGAPORE, May 22, 2024 (GLOBE NEWSWIRE) -- AI-Media, world leaders in AI-powered captioning solutions, announces its participation in the Broadcast Asia Expo 2024, held from May 29th to 31st at the Singapore Expo. At Booth #5L3-3, AI-Media will unveil its latest advancements in broadcast caption...

AIM - AIM ImmunoTech to Participate in Two Upcoming Investor Conferences

OCALA, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that AIM Chief Executive Officer Thomas K. Equels will participate in two upcoming investor conferences. Details for th...

AIM - AIM Stock Earnings: AIM ImmunoTech Misses EPS for Q1 2024

2024-05-16 11:52:41 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips AIM ImmunoTech (NYSEMKT: AIM ) just reported results for the first quarter of 2024. AIM ImmunoTech reported earnings per share of -12 cents. This was below the analyst est...

AIM - AIM ImmunoTech Inc. (AIM) Q1 2024 Earnings Call Transcript

2024-05-16 11:24:09 ET AIM ImmunoTech Inc. (AIM) Q1 2024 Earnings Conference Call May 16, 2024 08:30 AM ET Company Participants Thomas Equels - CEO Christopher McAleer - Scientific Officer Conference Call Participants James Molloy - Alliance Global Partne...

AIM - AIM ImmunoTech GAAP EPS of -$0.12

2024-05-16 07:33:17 ET More on AIM ImmunoTech AIM ImmunoTech Inc. (AIM) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on AIM ImmunoTech Historical earnings data for AIM ImmunoTech Financial information for AIM ImmunoTech Read ...

AIM - AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update

Continued execution across Ampligen ® clinical development programs and growing body of positive data in multiple high-value indications Company to host conference call and webcast today, May 16, at 8:30 AM ET OCALA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech...

Next 10